Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
48.8M
-
Shares change
-
-1.01M
-
Total reported value, excl. options
-
$8.09B
-
Value change
-
-$126M
-
Put/Call ratio
-
3.18
-
Number of buys
-
103
-
Number of sells
-
-88
-
Price
-
$165.76
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2019
251 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q4 2019.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.8M shares
of 1.39B outstanding shares and own 3.53% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11.8M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (5.47M shares), FMR LLC (5.4M shares), Capital International Investors (4.55M shares), WELLINGTON MANAGEMENT GROUP LLP (2.29M shares), Temasek Holdings (Private) Ltd (2.27M shares), BlackRock Inc. (1.96M shares), VANGUARD GROUP INC (1.26M shares), PRIMECAP MANAGEMENT CO/CA/ (999K shares), and CAPITAL INTERNATIONAL INC /CA/ (961K shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.